The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

Shao, A., & Owens, D. M. (2023). The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy. Oncotarget, 14(1), 96–103. https://doi.org/10.18632/oncotarget.28354
Authors:
Anqi Shao
David M Owens
Affiliated Authors:
Anqi Shao
David M Owens
Columbia Affiliation:
Subjects:
Neoplasms (MeSH)
Author Keywords:
cd200 receptor
immune checkpoint inhibition
immunotherapy
oncoimmunology
tumor microenvironment
elink
Publication Type:
Article
Unique ID:
10.18632/oncotarget.28354
PMID:
36738455
DOI:
10.18632/oncotarget.28354
Journal:
Oncotarget
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: